1. In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
   Agnieszka Karbownik et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
2. Is the Neutrophil-to-Lymphocyte Ratio a Useful Prognostic Indicator in Melanoma Patients?
   Joshua T Cohen et al, 2020, Melanoma Management CrossRef
3. Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
   Xuenan Peng et al, 2023, Frontiers in Oncology CrossRef
4. Neutrophils as potential therapeutic targets in hepatocellular carcinoma
   Daniel Geh et al, 2022, Nature Reviews Gastroenterology & Hepatology CrossRef
5. Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma
   Young Mi Hong et al, 2020, BMC Cancer CrossRef
6. Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal
   Li Li et al, 2022, BMC Cancer CrossRef
7. Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
   Lixing Liu et al, 2020, Frontiers in Oncology CrossRef
8. Prediction and verification of the prognostic biomarker SLC2A2 and its association with immune infiltration in gastric cancer
   Weijian Zhang et al, 2023, Oncology Letters CrossRef
9. Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment
   Sarah Berhane et al, 2019, British Journal of Cancer CrossRef